Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03859076 · ClinicalTrials.gov registry record · NA
UH3 Phase - Mindfulness-Based Blood Pressure Reduction (MB-BP) : Stage 2a RCT
A NA study, sponsored by Brown University.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
NCT03859076 is a NA study that has completed, run by Brown University. The registered enrollment target is 119 participants.
The verdict
NCT03859076, a NA study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
Study Summary
The primary aim is to identify the impacts of a behavioral intervention called "Mindfulness-Based Blood Pressure Reduction" (MB-BP) vs. enhanced usual care on the primary self-regulation target, specifically an assay of self-related processes (Multidimensional Assessment of Interoceptive Awareness) (MAIA) at 6 months, via a randomized controlled trial.
Interventions
- OTHER Enhanced Usual Care Control
- BEHAVIORAL MB-BP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2018-12-13 |
| Est. Completion | 2020-11-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03859076
The ClinicalTrials.gov registry entry for NCT03859076 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enhanced Usual Care Control is the first listed.
NCT03859076 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03859076 about?
NCT03859076 is a clinical study titled "UH3 Phase - Mindfulness-Based Blood Pressure Reduction (MB-BP) : Stage 2a RCT". The primary aim is to identify the impacts of a behavioral intervention called "Mindfulness-Based Blood Pressure Reduction" (MB-BP) vs. enhanced usual care on the primary self-regulation target, specifically an assay of self-related processes (Multidimensional Assessment of Interoceptive Awareness) ...
What is the current status of trial NCT03859076?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2018-12-13. Estimated completion is 2020-11-12.
What interventions are being tested in trial NCT03859076?
The interventions under investigation include: Enhanced Usual Care Control (OTHER), MB-BP (BEHAVIORAL).
Who is sponsoring clinical trial NCT03859076?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.